Bhagyashri Navalkele

Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin–Tazobactam Compared to Those on Vancomycin and Cefepime

Bhagyashri Navalkele, Jason M. Pogue, Shigehiko Karino et al. · Clinical Infectious Diseases · 2016 · 181 citations · Full text

Medicine, Nephrology, Pharmacotherapy +15

Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial Stewardship

Shigehiko Karino, Keith S. Kaye, Bhagyashri Navalkele et al. · Antimicrobial Agents and Chemotherapy · 2016 · 63 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Clinical and Economic Benefits of Fidaxomicin Compared to Vancomycin for Clostridium difficile Infection

Jason C Gallagher, Joseph Reilly, Bhagyashri Navalkele et al. · Antimicrobial Agents and Chemotherapy · 2015 · 58 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Comparison of complications in midlines versus central venous catheters: Are midlines safer than central venous lines?

Ammara Mushtaq, Bhagyashri Navalkele, Maninder Kaur et al. · American Journal of Infection Control · 2018 · 54 citations

Medicine, Surgery, Patient Safety +11

Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials

Alfredo J Mena Lora, Jessica E. Long, Yunda Huang et al. · JAMA Network Open · 2023 · 37 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16